In an effort to improve UK competitiveness in life sciences research, biotech nonprofit Medicines Discovery Catapult has kicked off its Virtual R&D Discovery Services Platform, which features twenty-two partnerships with various UK contract research organizations (CROs).
The platform offers a matching service that helps small- and medium-sized enterprises (SMEs) in the UK link up with participating specialist, private sector CROs to propel drug discovery. It also offers members tools like comprehensive project reviews, data package assessments and development plan advisement.
“Drug discovery is complex, costly and multi-skilled. The industry has moved from a fully integrated model, to one which is performed through a ‘virtual’, or fully outsourced approach,” the nonprofit said. “It is also increasingly reliant on SMEs as a source of innovation.”